Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.

Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Abstract Text:

    masaki akimotoMasaki Akimoto,kakushi matsushitaKakushi Matsushita,yukio surugaYukio Suruga,noriko aokiNoriko Aoki,atsuo ozakiAtsuo Ozaki,kimiharu uozumiKimiharu Uozumi,chuwa teiChuwa Tei,naomichi arimaNaomichi Arima,

    OBJECTIVE: Human T lymphotropic virus type I (HTLV-I) may be associated with some connective tissue autoimmune diseases, including systemic lupus erythematosus (SLE). To determine the relationship between HTLV-I infection and SLE, we examined the clinical manifestations of SLE patients with HTLV-I infection. METHODS: Eighty-nine patients with SLE were screened for antibodies to HTLV-I by electrochemiluminescence immunoassay. The presence of HTLV-I proviral sequences in peripheral blood mononuclear cells (PBMC) was determined by real-time polymerase chain reaction (PCR) quantification and Southern blotting analysis. The differences in clinical manifestations between HTLV-I-seropositive and seronegative patients with SLE were analyzed statistically. RESULTS: Fourteen of 89 (15.7%) patients were HTLV-I seropositive. All PBMC samples from 11 patients tested by PCR and 3 samples from 10 patients tested by Southern blotting analysis were positive for HTLV-I-related sequences. The age of HTLV-I-seropositive patients with SLE was significantly higher than that of seronegative patients (median 60 vs 42 yrs; p < 0.0005). The age at onset of SLE in HTLV-I-seropositive patients was also significantly higher than that of seronegative patients (median 45.5 vs 30 yrs; p <0.0005). The lymphocyte count in HTLV-I-seropositive SLE patients was significantly higher than that of seronegative patients (median 1740 vs 1066/microl; p = 0.027). The maintenance dose of prednisolone in HTLV-I-seropositive patients with SLE was significantly lower than that in seronegative patients (median 5 vs 9 mg/day; p = 0.012). CONCLUSION: This is the first report of the differences in clinical manifestations between SLE patients with and without HTLV-I infection. Our results suggest some involvement of HTLV-I in the pathogenesis of SLE.

    Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Publishing Authors By Initials

    m akimotoM Akimoto,k matsushitaK Matsushita,y surugaY Suruga,n aokiN Aoki,a ozakiA Ozaki,k uozumiK Uozumi,c teiC Tei,n arimaN Arima,

    For similar diagnosis: laboratory techniques and procedures: immunologic tests: serologic tests research abstracts see: diagnosis: laboratory techniques and procedures: immunologic tests: serologic tests research

    PUBMED ID PMID:

    MEDLINE DATE:

    Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of rheumatology

    VOLUME: 34

    Page Numbers: 1841-8

    Journal Abbreviation: J. Rheumatol.

    ISSN: 0315-162X

    DAY: 1

    MONTH: 08

    YEAR: 2007

    Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7501984

    Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Keywords Mesh Terms:

    KEYWORDS: Serologic Tests

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. Information

    Substance Name: Prednisolone

    Registry Number: 50-24-8

    Grant and Affiliation Information for Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.

    AFFILIATION: Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan. akimoto@m3.kufm.kagoshima-u.ac.jp

    Country: Canada

    Canada Research PublicationCanada Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Rheumatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News